(1)
Silverberg, J.; Barbarot, S.; Gooderham, M.; Simon, J.; Simpson, E.; Kurbasic, A.; Olsen, C.; Cork, M. Specifically Targeting Interleukin-13 With Tralokinumab Improved Sleep in Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials in Patients With Atopic Dermatitis. J of Skin 2021, 5, s9.